Results 201 to 210 of about 72,581 (277)

Parkinson\u27s disease and multiple system atrophy have distinct α-synuclein seed characteristics [PDF]

, 2019
Cairns, Nigel J., Dhavale, Dhruva D., Diamond, Marc I., Furman, Jennifer L., Holmes, Brandon B., Kotzbauer, Paul T., Song, Eun-Suk, Su, Bryant W., Yamasaki, Tritia R.   +8 more
core   +1 more source

Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study. [PDF]

Mov Disord
Diaz-Galvan P, Przybelski SA, Lesnick TG, Murray ME, Nguyen A, Reichard RR, Dickson DW, Ono D, Senjem ML, Schwarz CG, Gunter J, Lowe V, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Ramanan VK, Jones D, Botha H, St Louis EK, Knopman D, Day GS, Graff-Radford N, Kremers W, Petersen RC, Jack CR, Ferman TJ, Boeve BF, Kantarci K.   +28 more
europepmc   +1 more source

Genome-wide association analysis identifies APOE as a mitophagy modifier in Lewy body disease. [PDF]

Alzheimers Dement
Hou X, Heckman MG, Fiesel FC, Koga S, Soto-Beasley AI, Watzlawik JO, Zhao J, Valentino RR, Johnson PW, White LJ, Quicksall ZS, Reddy JS, Bras J, Guerreiro R, Zhao N, Bu G, Dickson DW, Ross OA, Springer W.   +18 more
europepmc   +1 more source

White Matter Hyperintensities and Cholinergic Degeneration as Lewy Body Disease [PDF]

Alzheimers Dement
Kang S, Jeon S, Ye B.
europepmc   +2 more sources

Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum. [PDF]

Brain
Mastrangelo A, Mammana A, Hall S, Stomrud E, Zenesini C, Rossi M, Janelidze S, Ticca A, Palmqvist S, Magliocchetti F, Baiardi S, Mattsson-Carlgren N, Hansson O, Parchi P.   +13 more
europepmc   +1 more source

Cerebral microbleeds: prevalence and relationship to clinical features in cognitive impairment with lewy body disease. [PDF]

BMC Neurol
Ren Z, Gan J, Chen Z, Shi Z, Liu S, Lu H, Zhang G, Ji Y.   +7 more
europepmc   +1 more source